MAPT and early-onset autosomal dominant Alzheimer disease: In the detection of in vivo pathological hallmarks in Alzheimer’s disease, such as markers of amyloid burden, tau pathology and neurodegeneration, the ALPS method might be an imaging biomarker for amyloid burden or tau pathology.